Mechanism of lymph node metastasis in prostate cancer.
Detection of lymph node metastases indicates poor prognosis for prostate cancer patients. Therefore, elucidation of the mechanism(s) of lymph node metastasis is important to understand the progression of prostate cancer and also to develop therapeutic interventions. In this article, the known mechanisms for lymph node metastasis are discussed and the involvement of lymphatic vessels in prostate cancer lymph node metastasis is comprehensively summarized. In addition, contradictory findings regarding the importance of lymphangiogenesis in facilitating lymph node metastasis in prostate cancer are pointed out and reconcilation is attempted.
Datta
Kaustubh
K
Department of Biochemistry & Molecular Biology, Gugg 17-93, Mayo Clinic Foundation, Rochester, MN 55905, USA. datta.kaustubh@mayo.edu
Muders
Michael
M
Zhang
Heyu
H
Tindall
Donald J
DJ
D006801:Humans; D042583:Lymphangiogenesis / Q000502:physiology*; D008207:Lymphatic Metastasis / Q000473:pathology*; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*
Mod Pathol. 2002 Apr;15(4):434-40
11950918
J Cell Physiol. 2005 Jan;202(1):205-14
15389531
Ann N Y Acad Sci. 2008;1131:225-34
18519975
Semin Perinatol. 2000 Feb;24(1):75-8
10709865
FASEB J. 2002 Jul;16(9):922-34
12087053
Cancer Res. 2000 Nov 1;60(21):6111-5
11085535
Eur Urol. 2009 Jun;55(6):1251-65
19297079
Cancer Res. 2000 Aug 15;60(16):4324-7
10969769
Blood. 2005 Jun 15;105(12):4642-8
15746084
Nat Med. 2001 Feb;7(2):192-8
11175850
Cancer Cell. 2002 Apr;1(3):219-27
12086857
BJU Int. 2009 Sep;104(5):592-7
19594740
Nat Med. 2001 Feb;7(2):186-91
11175849
Cancer Res. 2001 Mar 1;61(5):1786-90
11280723
EMBO J. 2005 Aug 17;24(16):2885-95
16052207
Oncogene. 2006 Aug 17;25(36):4965-74
16568082
Prostate. 2010 Feb 15;70(3):276-87
19827050
Cancer Sci. 2009 Jun;100(6):983-9
19385973
EMBO J. 2002 Apr 2;21(7):1505-13
11927535
Arch Med Res. 2009 May;40(4):268-75
19608016
Cancer Res. 2004 Jul 1;64(13):4400-4
15231646
Hum Pathol. 2008 Apr;39(4):610-5
18284936
Cancer Res. 2005 Jun 1;65(11):4739-46
15930292
Trends Cell Biol. 2005 Aug;15(8):434-41
16005628
J Urol. 2004 Jul;172(1):103-7
15201747
Pathol Res Pract. 2006;202(2):93-8
16413692
Cancer Res. 2005 Feb 15;65(4):1164-73
15734999
Am J Pathol. 2005 Mar;166(3):913-21
15743802
Int J Cancer. 2009 Dec 15;125(12):2747-56
19569051
Int J Cancer. 2007 Nov 15;121(10):2153-61
17583576
Cancer Res. 2005 Nov 1;65(21):9789-98
16267000
Oncogene. 2007 May 10;26(21):2997-3005
17130836
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1422-8
11381041
Cancer Res. 2003 Mar 15;63(6):1166-71
12649170
EMBO J. 1996 Apr 1;15(7):1751
8612600
Nat Rev Cancer. 2008 Aug;8(8):604-17
18497750
Am J Pathol. 2008 Dec;173(6):1891-901
18988807
Cancer. 1999 Dec 1;86(11):2406-12
10590384
J Natl Cancer Inst. 2001 Nov 7;93(21):1638-43
11698568
Blood. 2006 May 1;107(9):3531-6
16424394
Cancer Res. 2009 Aug 1;69(15):6042-8
19638584
Eur Urol. 2009 May;55(5):1003-11
19211184
Br J Cancer. 1999 May;80(3-4):569-78
10408868
J Biol Chem. 1998 Mar 20;273(12):6599-602
9506953
Clin Cancer Res. 2001 Mar;7(3):462-8
11297234
Cancer. 2001 Jan 1;91(1):66-73
11148561
BMC Cancer. 2009 Oct 12;9:362
19821979
Development. 1996 Dec;122(12):3829-37
9012504
World J Gastroenterol. 2004 Nov 15;10(22):3261-3
15484296
Mod Pathol. 2006 Mar;19(3):392-8
16400321
Nat Cell Biol. 2002 Jan;4(1):E2-5
11780131
Cancer Cell. 2008 Apr;13(4):331-42
18394556
Cancer Res. 2008 Nov 1;68(21):8770-8
18974119
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5026-31
17360402
Cancer Cell. 2006 Mar;9(3):209-23
16530705
Leukemia. 2004 Jun;18(6):1054-8
15057248
Am J Pathol. 1993 Aug;143(2):401-9
7688183
J Cell Biol. 1999 Feb 22;144(4):789-801
10037799
J Surg Res. 2011 May 15;167(2):267-72
19783007
Lab Invest. 2002 Sep;82(9):1255-7
12218087
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70
7724599
Prostate. 2004 Feb 1;58(2):193-9
14716745
Cancer Res. 2005 Oct 15;65(20):9261-8
16230387
Oncogene. 2007 Mar 15;26(12):1731-8
16964283
Cancer Res. 2007 Jan 15;67(2):593-9
17234768
Surg Oncol. 2009 Sep;18(3):213-8
19269808
Cancer Res. 2005 Aug 1;65(15):6901-9
16061674
Prostate. 2005 Oct 1;65(2):110-6
15880525
Cardiovasc Res. 2008 May 1;78(2):315-23
18065770
Nat Immunol. 2004 Jan;5(1):74-80
14634646
Prostate. 2005 Nov 1;65(3):222-30
15948136
Oncogene. 2005 Aug 18;24(35):5510-20
15897888
Dev Cell. 2002 Sep;3(3):411-23
12361603
FASEB J. 2007 Apr;21(4):1088-98
17242158
J Natl Cancer Inst. 2007 Jan 17;99(2):109-11
17227994
EMBO J. 2001 Feb 15;20(4):672-82
11179212
BJU Int. 2006 Oct;98(4):903-6
16978291
J Pathol. 2005 Jun;206(2):170-7
15846845
Prostate. 2008 Jul 1;68(10):1057-63
18386298
Am J Pathol. 1999 Feb;154(2):385-94
10027397
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6012-7
17062674
Eur J Cancer. 2007 Jul;43(11):1748-54
17570654
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53
9435229
Head Neck. 2010 Jun;32(6):786-92
19890908
Clin Cancer Res. 2004 Aug 1;10(15):5137-44
15297417
Breast J. 2000 Jul;6(4):225-232
11348370
Semin Cancer Biol. 2009 Oct;19(5):285-97
19482087
Cancer Cell. 2004 Oct;6(4):333-45
15488757
J Exp Med. 2002 Dec 2;196(11):1497-506
12461084
J Exp Med. 2005 Apr 4;201(7):1089-99
15809353
Cancer Res. 2008 Oct 1;68(19):7828-37
18829538
Nature. 2005 Dec 15;438(7070):946-53
16355212
Br J Cancer. 1999 Apr;80(1-2):309-13
10390013
Oncol Rep. 2003 Nov-Dec;10(6):1747-51
14534690
Eur Urol. 2009 Feb;55(2):261-70
18838212
Prostate. 1998 Apr 1;35(1):71-80
9537602
Cancer Res. 2006 Oct 1;66(19):9566-75
17018613
Nat Rev Immunol. 2006 Sep;6(9):659-70
16932751
FASEB J. 2006 Jul;20(9):1462-72
16816121
Blood. 2007 Feb 1;109(3):1010-7
17032920